Terms: = Head and neck cancer AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA AND Prognosis
3 results:
1. Tumor-infiltrating immune cells and survival in head and neck squamous cell carcinoma: a retrospective computational study.
Zhang L; Wang WQ; Chen JH; Feng J; Liao YZ; Zou Y; Liu R
Sci Rep; 2024 Mar; 14(1):6390. PubMed ID: 38493212
[TBL] [Abstract] [Full Text] [Related]
2. Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery.
Kono M; Kumai T; Hayashi R; Yamaki H; Komatsuda H; Wakisaka R; Nagato T; Ohkuri T; Kosaka A; Ohara K; Kishibe K; Takahara M; Katada A; Hayashi T; Celis E; Kobayashi H; Harabuchi Y
Cancer Immunol Immunother; 2021 Dec; 70(12):3421-3434. PubMed ID: 33866408
[TBL] [Abstract] [Full Text] [Related]
3. Downregulated MEG3 contributes to tumour progression and poor prognosis in oesophagal squamous cell carcinoma by interacting with miR-4261, downregulating DKK2 and activating the Wnt/β-catenin signalling.
Ma J; Li TF; Han XW; Yuan HF
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1513-1523. PubMed ID: 30990378
[TBL] [Abstract] [Full Text] [Related]
